CovidVax

The latest info on
Covid-19 Vaccines

DistributionFull ListCategories
Number of vaccines, at each stage:
early
development
50+
testing
on animals
65
testing
on humans
56
ready for
distribution
12

Ready for distribution (12)

vaccine researcher country started
Inactivated Sinovac China + Brazil December 2020
Inactivated Beijing Institute of BioProducts (Sinopharm) China December 2020
Inactivated Wuhan Institute of BioProducts (Sinopharm) China December 2020
Sputnik V Gamaleya Research Institute Russia December 2020
mRNA Comirnaty BioNTech + Pfizer Germany + USA December 2020
mRNA-1273 Moderna + NIAID USA January 2021
AZD 1222 Oxford University + AstraZeneca UK January 2021
Covaxin Bharat Biotech India January 2021
single-dose Ad26 Janssen (Johnson & Johnson) Belgium + USA February 2021
EpiVacCorona FBRI SRC VB VECTOR Russia March 2021
Inactivated QazCovid-In Research Institute for Biological Safety Problems Republic of Kazakhstan Kazakhstan April 2021
single-dose Ad5-nCoV CanSino Biologics + Beijing Institute of BioTech China + Canada May 2021
Latest updates on these vaccines:
Mar 11J&J announced that the CHMP of the EMA issued a positive opinion to recommend the Conditional Market Authorization for its vaccine
Mar 11J&J announced that the European Commission has granted a Conditional Marketing Authorization for its vaccine
Mar 10Moderna enrolled 60 participant previously vaccinated to evaluate booster vaccine candidate against South African variant
Mar 09Russia has signed a deal with Adienne Srl to produce Sputnik V vaccine in Italy planning to make 10 million doses this year
Mar 08Baxter BioPharma Solutions announced an agreement for fill/finish manufacturing of the company's vaccine in the US
Mar 05J&J announced that Health Canada has granted an Interim Order authorization for its single-shot vaccine
Mar 04The RDIF announced the start of a rolling review procedure of Sputnik V vaccine against coronavirus by EMA
Mar 04RDIF announced the approval of the Russian Sputnik V vaccine by the Ministry of Health of the Republic of Iraq
Mar 03Bharat Biotech announced the first interim analysis of its BBV152 showing that the vaccine was well tollerated in a group of 25800 subjects
Mar 02Merck has entered into multiple agreements to support efforts to help produce J&J's COVID-19 vaccine

Testing on humans (56)

vaccine researcher country started people
on trial
Recomb. Novavax USA May 6
2020
48035
@ Ph. 3
Protein subunit FR2 Instituto Finlay de Vacunas Cuba Nov 2
2020
44960
@ Ph. 3
mRNA CureVac + Bayer Germany Jun 18
2020
39964
@ Ph. 3
Inactivated Institute of Medical Biology + Chinese Academy of Medical Sciences Singapore + China May 15
2020
35433
@ Ph. 3
PD-VLP Medicago Canada Jul 10
2020
31710
@ Ph. 2-3
RBD-Dimer Anhui Zhifei Longcom Biopharma + Institute of Microbiology Chinese Academy of Sciences China Jun 22
2020
30216
@ Ph. 3
DNA INO-4800 Inovio Pharma USA + China Apr 3
2020
7498
@ Ph. 2-3
RBD West China Hospital Sichuan University China Aug 28
2020
5128
@ Ph. 2
CpG 1018 Medigen Vaccine Biologics Corp + NIAID Taiwan + USA Sep 01
2020
3745
@ Ph. 2
Inactivated Beijing Minhai Biotech + Shenzhen Kangtai China Oct 7
2020
1180
@ Ph. 2
S protein Sanofi Pasteur + GSK France + UK Sep 3
2020
1160
@ Ph. 2
DNA ZyCoV-D Zydus Cadila India Jul 13
2020
1048
@ Ph. 1-2
single-dose VSV-S Israel Institute for Biological Research Israel Oct 26
2020
1040
@ Ph. 1-2
mRNA Arcturus Tx + Duke-NUS USA + Singapore Jul 22
2020
791
@ Ph. 2
single-dose RBD Wantai Biopharma China Sep 1
2020
780
@ Ph. 2
eVLP VBI Vaccines USA + Canada Feb 15
2021
780
@ Ph. 1-2
Protein subunit FR1 Instituto Finlay de Vacunas Cuba Oct 19
2020
736
@ Ph. 1-2
Recomb. Nanogen Pharma Biotech Vietnam Dec 10
2020
620
@ Ph. 1-2
DNA Osaka University + AnGes Japan + USA Jun 29
2020
560
@ Ph. 2-3
NDV-HXP-S Mahidol University Thailand + USA Mar
2021
460
@ Ph. 1-2
RBD Biological E India Nov 16
2020
360
@ Ph. 1-2
GX-19 DNA Genexine Inc. + Binex South Korea + Indonesia Jun 17
2020
360
@ Ph. 1-2
DNA GeneOne Life Science South Korea Dec 23
2020
345
@ Ph. 1-2
saRNA Imperial College London UK Jun 4
2020
320
@ Ph. 1
mRNA People's Liberation Army Academy of Military Sciences China Jun 25
2020
288
@ Ph. 1
VLP SpyBiotech + Serum Institute of India UK + India Aug 17
2020
280
@ Ph. 1-2
Recomb. SK Bioscience South Korea Jan 20
2021
260
@ Ph. 1-2
single-dose dendritic Aivita Biomedical Indonesia Dec 7
2020
229
@ Ph. 1-2
RBD+alum Center for Genetic Engineering and Biotech (CIGB) Cuba Dec 7
2020
212
@ Ph. 1-2
RBD Kentucky BioProcess. (British American Tobacco) USA Jul 31
2020
180
@ Ph. 1-2
intranasal Altimmune + University of Alabama USA Feb
2021
180
@ Ph. 1
single-dose adenovirus Cellid + IAVI South Korea Dec 29
2020
150
@ Ph. 1-2
Inactivated VLA 2001 Valneva + Dynavax France + USA Dec 16
2020
150
@ Ph. 1-2
Trimeric S protein Clover Biopharma China Jun 19
2020
150
@ Ph. 1
Ad5-nCoV CanSino Biologics + Institute of Biotech China Sep 29
2020
144
@ Ph. 1
hAd5 ImmunityBio + NantKwest USA Oct 19
2020
135
@ Ph. 1
Recomb. Razi Vaccine and Serum Research Institute Iran Jan 29
2021
133
@ Ph. 1
fusion protein University Groningen + Akston Biosciences Netherlands + USA Jan 18
2021
130
@ Ph. 1-2
MVA City of Hope Medical Center USA Nov 25
2020
129
@ Ph. 1
single-dose DNA oral Symvivo Canada Apr 30
2020
112
@ Ph. 1
aAPC Shenzhen GenoImm. Medical Institute China Feb 15
2020
100
@ Ph. 1
single-dose dendritic Shenzhen GenoImm. Medical Institute China Mar 24
2020
100
@ Ph. 1-2
single-dose adenovirus ReiThera + Leukocare Italy + Germany + Belgium Aug 10
2020
90
@ Ph. 1
RBD+AgnHB Center for Genetic Engineering and Biotech (CIGB) Cuba Dec 7
2020
88
@ Ph. 1-2
S protein Adimmune Taiwan Aug 20
2020
70
@ Ph. 1
MVP Covaxx + University of Nebraska Medical Center (UNMC) USA Sep 1
2020
60
@ Ph. 1
mRNA Providence Tx Canada Jan 14
2021
60
@ Ph. 1
Inactivated Shifa Pharmed Industrial Co Iran Dec 21
2020
56
@ Ph. 1
VAAST oral Vaxart USA Sep 24
2020
48
@ Ph. 1
Attenuated Codagenix + Serum Institute of India USA + India Dec
2020
48
@ Ph. 1
single-dose S protein Vaxine + Flinders University Australia + UK Jun 30
2020
40
@ Ph. 1
CORVax12 OncoSec Medical + Providence USA Dec
2020
36
@ Ph. 1
single-dose peptides University Hospital Tuebingen Germany Sep 30
2020
36
@ Ph. 1
MVA-S encoded German Center for Infection Research (DZIF) + Ludwig-Maximilians University of Munich Germany Oct 20
2020
30
@ Ph. 1
RNA - GLS - 5310 GeneOne Life Science + Houston Methodist South Korea + USA 0
@ Ph. 
S protein Shionogi + UMN Pharma Japan 0
@ Ph. 
Latest updates on these vaccines:
Mar 08ImmunityBio announced that the first cohorts of their South Africa and US COVID-19 vaccine trials have received their initial doses of the company's vaccine
Mar 08Soberana 02 started Phase 3 clinical trials Monday in the capital Havana with a population segment between 19 to 64 years of age
Mar 04Head of clinical studies of the Iranian COVID-19 vaccine said that the results of the serum immunogenicity have been very good so far
Feb 26Novavax and Takeda have finalized license agreement for Novavax's vaccine in Japan with Takeda already dosed the first participants in a Phase 1/2 clinical trial
Feb 25Altimmune single-dose intranasal COVID-19 vaccine has started its Phase 1 clinical trial with up to 180 healthy volunteers
Feb 25Vaxart announced that it plans to start the first Phase 2 study of its oral vaccine candidate in Q2 2021
Feb 22Novavax announced the enrollment of PREVENT-19 its Phase 3 study in the US and Mexico to evaluate safety and efficacy of the vaccine
Feb 11FDA has authorized Immunity Bio to expand Phase 1 testing of a bivalent hAD5 T-cell COVID-19 vaccine
Feb 07Cuban's vaccine Soberana 02 will start its Phase 3 trial in March by enrolling 42600 participants
Feb 05SK Bioscience said it has begun conducting clinical studies on two COVID-19 vaccine candidates

Testing on animals (65)

vaccine researcher country started human
trials
AVI-205 AbVision USA
Unknown Adeleke University Nigeria
Spike protein Axon Neuroscience Slovakia
single-dose BBV154 Bharat Biotech India Mar 1
2021
Rabies vector Bharat Biotech + Thomas Jefferson University India + USA Apr
2020
DNA BioNet-Asia + Technovalia + Vax4COVID Alliance Thailand + France + Australia Apr
2020
Feb 15
2021
mRNA Biocad Russia late Apr
2020
Unknown Catholic University + Millenium Institute of Immunology and Imm.therapy Chile
MVA Centro Nacional Biotecnol. (CNB-CSIC) Spain May
2020
Self amplifying RNA Chimeron Bio + George Madison University's National Center for Biodefense and Infectious Disease USA
mRNA China CDC + Tongji University China Feb
2020
DNA Chula Vaccine Research Center + National Research Council of Thailand Thailand May
2020
Jan
2021
exoVACC Codiak BioSciences + Ragon Institute USA
mRNA CureVac + GSK Germany + UK
mRNA CureVac + UK Government Germany + UK
srRNA Elixirgen Tx USA
Unknown Emergex Vaccines + George Mason University's National Center for Biodefense and Infectious Diseases (NCIBD) UK + Canada
Inactivated Erciyes University Turkey May
2020
Nov 5
2020
Subunit FBRI SRC VB VECTOR Russia
VSV Vector FBRI SRC VB VECTOR Russia
mRNA FBRI SRC VB VECTOR Russia
Measles Vector FBRI SRC VB VECTOR Russia
Recomb. FBRI SRC VB VECTOR Russia
Peptide Flow Pharma USA Apr
2020
MVA-VLP GeoVax + BravoVax USA + China Mar
2020
Q4
2020
Plasmid DNA Globe Biotech Limited Bangladesh Jul
2020
HSP70 HaloVax USA late Apr
2020
gp-96 Heat Biologics (Zolovax) USA Apr
2020
Protein subunit IMV Canada Apr
2020
Q3
2020
VLP Icosavax USA Oct
2020
Spike-based Immuno Precise + LiteVax BV Canada + Holland Aug
2020
saRNA Infectious Disease Research Institute + Amyris USA
Protein subunit InnoMedica Switzerland
Intranasal Institut Pasteur + TheraVectys France
Protein subunit MOGAM Institute for Biomedical Research + GC Pharma Korea
AAVCOVID Massach.tts Eye and Ear + AveXis USA + Spain May
2020
mRNA Max Planck Institute of Colloids and Interfaces Germany
Protein subunit Max-Planck Institute of Colloids and Interfaces Germany
Attenuated Meissa Vaccines INC USA Jun
2020
oral Migal Research Institute Israel Feb
2020
Q3
2020
Plasmid DNA National Institute of Chemistry Slovenia Aug
2020
IMT504 NidoVax USA
TerraCoV2 Oragenics (Noachis Terra) + Aragen Bioscience USA
Protein subunit PDS Biotech USA
Unknown Precision Vaccines Program at Boston Children's Hospital USA
RBD Saiba Switzerland Mar
2020
Aug
2020
mRNA Sanofi Pasteur + Translate Bio France + USA
Inactivated Selcuk University Turkey
CiVax Soligenix + University of Hawaii at Manoa USA
Recomb. Sorrento Tx USA Mar
2020
S protein St. Petersburg Scientific Research Institute of Vaccines and Serums Russia Mar
2020
DNA Statens Serum Institut Denmark
Linear DNA Takis Biotech + Applied DNA Sciences Italy + USA Apr
2020
Feb 3
2021
Unknown United Biomedical (UBI) + c19 Taiwan
Recomb. University of California Los Angeles (Horwitz Lab) USA
PIV5 University of Georgia + University of Iowa USA Apr
2020
skin patch University of Pittsburgh USA Mar
2020
Jun
2020
S protein VIDO-InterVac Canada Apr
2020
Jan
2020
S protein Vabiotech Vietnam May
2020
Nano particles (vaults) Vault Pharma + University of California Los Angeles USA
Peptide Vaxil Bio Israel Mar
2020
S protein Verndari + University of California Davis USA Apr
2020
Unknown Vir Biotech + GSK USA + UK
Chimeric Vivaldi Biosciences + Esco Aster Pte Ltd USA + Singapore
S protein WRAIR + USAMRIID USA Mar
2020
Latest updates on these vaccines:
Feb 18ChulaVRC vaccine has been successful in trials on mice and monkeys and is due to be tested on humans in late April or early May
Feb 13SanofiTranslate mRNA vaccine will not be ready this year with clinical trials expected to start this quarter
Feb 11A university in Turkey administrated the first dose of ERUCOV-VAC to a human volunteer on Wed in Phase 2 trials
Feb 08Takis' DNA vaccine could start its clinical trials in March after being approved by Italy's national drug regulator last week
Feb 05CureVac entered a collaboration with the UK Government to develop and manufacture potential vaccine candidates against variants
Feb 03GSK will also support the manufacture of up to 100 million doses of CureVac's COVID-19 vaccine
Feb 03Takis and Rottapharm Biotech announced the authorization of Phase 1/2 clinical trial of their vaccine by AIFA
Feb 03GSK and CureVac announced a new 150m euros collaboration to jointly develop next generation mRNA vaccines
Jan 29AAVCOVID vaccine led to robust neutralizing antibody responses in mouse and nonhuman primate models from only a single dose
Jan 28GeoVax announced that NIAID has awarded the company a Small Business Innovative Research grant in suppotrt of its vaccine development

In early development (50+)

vaccine researcher country animal
trials
human
trials
S protein AJ Vaccines Denmark
eVLP ARTES Biotech Germany
cVLP AdaptVac (PREVENT-nCoV EU consortium) Denmark + Netherlands + Germany Q4
2020
S1 - Fc AnyGo Technology China
Heat stable subunit Applied Biotech Institute USA
S1 or RBD Baylor College of Medicine USA
OMV BiOMVis + University of Trento Italy
intranasal Biocad + IEM Russia
mRNA-LNP CanSino Biologics + Precision Nanosystems China + Canada
RNA Centro Nacional Biotecnol. (CNB-CSIC) Spain
DNA DIOSynVax + University of Cambridge UK
VLP Doherty Institute Australia
DNA Entos Pharma Canada + USA Dec 1
2020
S protein EpiVax + University of Georgia USA
Adeno5 Erciyes University Turkey
VLP Fudan University + Shangai JiaoTong University China
RBD Fudan University + Shangai JiaoTong University China
Ii-Key peptide Generex + EpiVax Canada + USA
Measles Vector German Center for Infection Research (DZIF) + CanVirex AG Germany
mRNA GreenLight Biosciences USA
AD5 S Greffex USA
ISR-50 ISR Sweden Q2
2020
Q4
2020
Plasmid DNA Immunomic Tx + EpiVax USA
VLP Imophoron + Bristol University UK
Attenuated Indian Immunolog. + Griffith University India + Australia
S protein Innovax + Xiamen University Netherlands + China + UK
NDV Intravacc + Wageningen BioVeter. Research Netherlands
YF17D Vector KU Leuven Belgium
DNA Karolinska Institute (OpenCorona EU project) Sweden + Germany + Italy 2021
Nano particle LakePharma USA
DNA intranasal Mediphage Bioceuticals + University of Waterloo Canada
RBD-based Neovii + Tel Aviv University Switzerland + Israel
Unknown OSE ImmunoTx France
VLP OSIVAX France
S/M proteins OncoGen Romania
Inactivated Osaka University + BIKEN Japan
VLP Osaka University + BIKEN Japan
OMV Quadram Institute Bioscience UK
mRNA RNA immune USA
DNA SN14 Scancell UK Q1
2021
S protein Shionogi + NIID Japan Japan Dec 11
2020
Inactivated Sinovac + Dynavax China + USA
AD5 S oral Stabilitech UK
APMV The Lancaster University UK UK
TNX-1800 Tonix Pharma USA
Spike based University of Alberta Canada
Plant virus University of California San Diego USA
Dendritic cell-based University of Manitoba Canada
VLPs University of Sao Paulo Brasil
mRNA University of Tokyo + Daiichi Sankyo Japan
VSV - S University of Western Ontario Canada
M2SR University of Winsconsin + FluGen USA + India Q4
2020
AD + HLA Valo Tx UK
S protein Yisheng Biopharma China
ZIP-1642 Ziphius Tx + Ghent University Belgium
Measles Vector Zydus Cadila India
mRNA intranasal eTheRNA + Epivax Belgium + USA + Canada Q1
2021
Plant produced iBio + CC-Pharming USA + China
Latest updates on these vaccines:
Jan 12AdaptVac published in Nature Communications its preclinical studies showing strong virus neutralization for its virus like particle vaccine
Dec 18Scancell Holdings have finally selected their COVID-19 vaccine SN14 for further development and clinical trials
Dec 16Shionogi has initiated a Japanese Phase 1/2 clinical trial of a prophylactic vaccine candidate for COVID-19
Nov 16PREVENT-nCoV consortium member AdaptVac announced that its vaccine has been successfully manufactured
Nov 05OSE announced successful completion of its human ex vivo study and expects to start clinical trial in Q1 2021
Oct 27CambridgeUni received a multi-million dollar funding for clinical trial using PharmaJet's needle-free system to deliver vaccine
Oct 23Entos was awarded up to $5M in NRC IRAP funding to conduct Phase 1 clinical trial of its vaccine
Sep 17CambridgeUni's vaccine has shown excellent safety and immunogenicity in Phase 1-2 trials
Aug 31Daiichi Sankyo was selected by AMED to develop a vaccine
Aug 28Scientists at Nottingham's two leading universities have announced plans to begin clinical trials of Scancell's vaccine in Q1 2021


contact | about | ©2020 CovidVax.org project